Submitted by Anonymous (not verified) on 17 February 2026 - 8:40
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised